arrow_back Back to App

New TBI Treatments for Veterans: $30 Million for Innovative Neurorehabilitation Research.

This Act establishes a three-year, $30 million grant program to fund research and implementation of innovative, non-pharmacological neurorehabilitation treatments for veterans suffering from chronic mild Traumatic Brain Injury (mTBI). The goal is to improve veterans' mental health outcomes, reduce suicide risk factors, and mitigate the long-term effects of these injuries through patient-centered care. The program is designed to align with existing suicide prevention efforts and expand treatment options beyond traditional VA pathways.
Key points
Veterans with chronic mild TBI will gain access to new, innovative neurorehabilitation therapies, including non-drug treatments, focused on patient-centered care.
The program authorizes $30 million over three years (2026-2028) to fund studies testing the effectiveness of these new approaches in improving mental health and reducing suicide risk.
Funding supports partnerships between non-profits, academic institutions, and VA facilities to quickly implement and evaluate the best new treatment practices.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_3130
Sponsor: Sen. McCormick, David [R-PA]
Process start date: 2025-11-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Veterans TBI Adaptive Care Opportunities Nationwide Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_3130.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-11-06.

What are the main provisions?

Key points include:

  • Veterans with chronic mild TBI will gain access to new, innovative neurorehabilitation therapies, including non-drug treatments, focused on patient-centered care.
  • The program authorizes $30 million over three years (2026-2028) to fund studies testing the effectiveness of these new approaches in improving mental health and reducing suicide risk.
  • Funding supports partnerships between non-profits, academic institutions, and VA facilities to quickly implement and evaluate the best new treatment practices.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. McCormick, David [R-PA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Benefits